BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24743365)

  • 1. [A case of triple-negative breast cancer responding to multidisciplinary treatment containing bevacizumab].
    Noma M; Ohara M; Imaoka Y; Mashima H; Mizota S; Okimoto S; Takakura Y; Oishi K; Kohashi T; Ikeda S; Fudaba Y; Matsugu Y; Ishimoto T; Nakahara H; Urushihara T; Itamoto T; Doi M; Nishisaka T
    Gan To Kagaku Ryoho; 2014 Apr; 41(4):483-6. PubMed ID: 24743365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of locally advanced and metastatic breast cancer successfully treated with combination therapy of paclitaxel and bevacizumab].
    Miki M; Matsuo Y; Yoshida S; Tane K; Hirokaga K; Maekawa Y; Takao S
    Gan To Kagaku Ryoho; 2014 Aug; 41(8):1027-9. PubMed ID: 25132039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locally advanced breast cancer with bleeding - two cases effectively treated with bevacizumab plus weekly paclitaxel.
    Ishizuna K; Ninomiya J; Ogawa T; Kojima M; Kawashima M; Nozaki M; Yamagishi H; Ueda Y
    Gan To Kagaku Ryoho; 2014 May; 41(5):637-40. PubMed ID: 24917012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A complete response following treatment with Paclitaxel and bevacizumab for metastatic breast cancer].
    Tsubota Y; Sueoka N; Yamamoto D
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1954-6. PubMed ID: 25731387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent bevacizumab with a sequential regimen of doxorubicin and cyclophosphamide followed by docetaxel and capecitabine as neoadjuvant therapy for HER2- locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group.
    Rastogi P; Buyse ME; Swain SM; Jacobs SA; Robidoux A; Liepman MK; Pajon ER; Dy PA; Posada JG; Melnik MK; Piette F; Geyer CE; Mamounas EP; Wolmark N
    Clin Breast Cancer; 2011 Aug; 11(4):228-34. PubMed ID: 21684812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of recurrent breast cancer with carcinomatous pleurisy responding to bevacizumab and paclitaxel therapy].
    Sato Y; Nakagawa T; Sato T; Nagahara M; Sugihara K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2387-9. PubMed ID: 24394121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer.
    von Minckwitz G; Eidtmann H; Rezai M; Fasching PA; Tesch H; Eggemann H; Schrader I; Kittel K; Hanusch C; Kreienberg R; Solbach C; Gerber B; Jackisch C; Kunz G; Blohmer JU; Huober J; Hauschild M; Fehm T; Müller BM; Denkert C; Loibl S; Nekljudova V; Untch M; ;
    N Engl J Med; 2012 Jan; 366(4):299-309. PubMed ID: 22276820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative carboplatin-paclitaxel-bevacizumab in triple-negative breast cancer: final results of the phase II Ca.Pa.Be study.
    Guarneri V; Dieci MV; Bisagni G; Boni C; Cagossi K; Puglisi F; Pecchi A; Piacentini F; Conte P
    Ann Surg Oncol; 2015 Sep; 22(9):2881-7. PubMed ID: 25572687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
    Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prolonged remission achieved by using bevacizumab plus paclitaxel therapy combined with sequential radiotherapy for a rapidly growing chest wall recurrence of triple negative breast cancer - a case report].
    Kawashima M; Fujii K; Kiso M; Takeyama O; Kan S; Tanaka M
    Gan To Kagaku Ryoho; 2015 Jan; 42(1):81-4. PubMed ID: 25596684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of stage IV breast cancer with long-term partial response treated with tri-weekly paclitaxel plus bevacizumab].
    Okamoto A; Nakatsukasa K; Fujita Y; Sugimoto R; Sakaguchi K; Taguchi T
    Gan To Kagaku Ryoho; 2015 Mar; 42(3):343-6. PubMed ID: 25812504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of stage IV breast cancer with improved cancer pain using bevacizumab and paclitaxel].
    Ishiyama T; Jinguu A; Matsumoto H; Kikuchi J; Suzuki T
    Gan To Kagaku Ryoho; 2015 Mar; 42(3):347-9. PubMed ID: 25812505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of bevacizumab with paclitaxel for advanced breast cancer - a case report].
    Morishita A; Mitsuhashi S; Fujisawa F; Hirano M; Kojima H
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):761-4. PubMed ID: 23863653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preoperative therapy with trastuzumab and paclitaxel in a stage IV advanced breast cancer with complete pathologic response].
    Rai Y; Sagara Y; Sagara Y; Takahama T; Matsuyama Y; Ando M; Sagara Y; Ooi Y; Inoue K; Kurosumi M
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):65-8. PubMed ID: 17220672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of bone marrow carcinomatosis with disseminated intravascular coagulation arising from breast cancer successfully treated with paclitaxel plus bevacizumab].
    Kawai H; Sugimoto R; Miyauchi S; Yoshida R; Waki N; Hirayama S; Ishizaki M; Nishi H; Yamashita K
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1957-9. PubMed ID: 25731388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful neoadjuvant therapy with trastuzumab, paclitaxel and epirubicin for an elderly patient with inflammatory breast cancer.
    Shimizu T; Hirano A; Watanabe O; Kinoshita J; Kimura K; Kamimura M; Domoto K; Kim N; Ogawa K; Fujibayashi M
    Anticancer Res; 2010 Feb; 30(2):581-5. PubMed ID: 20332474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Two cases of breast cancer responding to primary systemic chemotherapy containing trastuzumab without surgery].
    Konishi K; Hasegawa N; Kaneko H; Iimura Y; Shoji Y; Kawabata M
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):115-8. PubMed ID: 20087043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
    Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
    Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Case of a patient with inflammatory breast cancer who responded to preoperative chemotherapy with paclitaxel plus bevacizumab and could subsequently undergo surgery].
    Kashiwagi S; Ishihara S; Ishii M; Asano Y; Watanabe M; Morisaki T; Aomatsu N; Noda S; Kawajiri H; Nakano T; Kawakami N; Mitsukawa Y; Takashima T; Onoda N; Ishikawa T; Hirakawa K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2384-6. PubMed ID: 24394120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.